Halozyme Therapeutics shares owned by Tygh Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Tygh Capital Management
from 13F filings
Historical chart of Tygh Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Tygh Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Tygh Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2021-12-31 | $3.4M | 85k | 40.21 |
| 2021-09-30 | $3.4M | 84k | 40.68 |
| 2021-06-30 | $3.4M | 75k | 45.41 |
| 2021-03-31 | $3.2M | 76k | 41.69 |
| 2020-12-31 | $3.1M | 73k | 42.71 |
| 2020-09-30 | $1.9M | 72k | 26.28 |